BioSpace News Archive

Agile Therapeutics, Inc. announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a virtual fireside chat as part of the 2020 RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2020 at 8:35 a.m. ET.

ChemoCentryx, Inc. announced financial results for the first quarter ended March 31, 2020 and provided an overview of the Company’s recent corporate highlights.

TG Therapeutics, Inc. announced its financial results for the first quarter ended March 31, 2020 and recent company developments.

Recent Equity Offering Strengthens Balance Sheet and Increases Operating Flexibility with focus on Brain Cancer Initiatives

Neurocrine Biosciences, Inc. and Idorsia Ltd announced, following Investigational New Drug application acceptance by the U.S. Food and Drug Administration, Neurocrine Biosciences has exercised its option to license the global rights of Idorsia’s ACT-709478.

Sutro Biopharma, Inc. announced a proposed underwritten public offering in which it intends to offer and sell shares of its common stock.

Expects to See Strong Volume of Orders from U.S. Military Following Milestone C Approval for DSUVIA

Titan Pharmaceuticals, Inc. announced that its first quarter 2020 financial results will be released on Friday, May 15, 2020.

Atara Biotherapeutics, Inc., a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including solid tumors, hematologic cancers and autoimmune diseases, announced the appointment of immunology and cell & gene therapy expert Maria Grazia Roncarolo, MD, to the Board of Directors.

Sangamo Therapeutics, Inc., a genomic medicine company, reported first quarter 2020 financial results and recent business highlights.